Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 24
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

C-section and the neonatal gut microbiome acquisition: consequences for future health

  • Arboleya, Silvia
  • Suárez, Marta
  • Fernández, Nuria
  • Mantecón, Laura
  • Solís, Gonzalo
  • Gueimonde Fernández, Miguel
  • González de los Reyes-Gavilán, Clara
[Background]: The human gut microbiota is assembled during infancy with an increase in diversity and stability. The correct colonization and the establishment of this microbiome are linked to the early and future health status of the individual. It is known that caesarean delivery alters this optimal microbial foundation. C-section (CS) is a common obstetrician surgery; however, it is not without risk for the mother/infant dyad. The World Health Organization recommends not exceeding 10–15% of the total deliveries; nevertheless, this rate has been increasing rapidly worldwide in the last decades. [Summary]: This review discloses the clinical parameters for correct CS recommendation. Moreover, the major microbial changes in the infant gut microbiome acquisition as a consequence of delivery mode and medical practices surrounding it, as well as, the early and long-lasting effects for both mother and babies are discussed. In addition, some strategies for the gut microbiota restoration are analysed. The aim of this review is to show the need for the development of strategies for minimizing or limiting the impact of caesarean on the microbiome development, favouring future health., This work was financed by the EU Joint Programming Initiative – A Healthy Diet for a Healthy Life (JPI HDHL, http://www.healthydietforhealthylife.eu/) and the Spanish Ministry of Economy and Competitiveness (MINECO; Project EarlyMicroHealth), and by project AGL2017–83653R from Plan Estatal de I+D+I (Spanish Ministry of Economy and Competitiveness). S.A. is the recipient of a postdoctoral Marie-Curie contract funded by the E.U., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fecal microbiota profile in a group of myasthenia gravis patients

  • Moris, Germán
  • Arboleya, Silvia
  • Mancabelli, Leonardo
  • Milani, Christian
  • Ventura, Marco
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
The intestinal microbiota plays a key role in the maintenance of human health. Alterations in this microbiota have been described in several autoimmune diseases, including nervous system diseases. Nevertheless, the information regarding neuromuscular conditions is still limited. In this study, we aimed at characterizing the intestinal microbiota composition in myasthenia gravis patients (MG). To this end fecal samples were taken from ten patients, with antibodies against the acetylcholine receptor, and ten age and sex matched controls from the same population (Asturias region, Spain). Fecal samples were submitted to microbiota analyses by 16S rRNA gene profiling, bifidobacterial ITS-region profiling and qPCR. The fecal levels of short chain fatty acids were determined by gas chromatography. MG patients were found to harbor lower relative proportions of Verrucomicrobiaceae and Bifidobacteriaceae, among others, and increased of the phylum Bacteroidetes and the family Desulfovibrionaceae. The increase of these latter microbial groups was also confirmed at quantitative level by qPCR. In contrast, no statistically significant differences were found between MG patients and the control group in the bifidobacterial population at the species level or in short chain fatty acids profiles. Our data indicates an altered fecal microbiota pattern in MG patients and point out at specific microbiota targets for intervention in this population., This work was financed by projects AGL2017-83653R from Plan Estatal de I + D + I (Spanish Ministry of Economy and Competitiveness), and by Grant GRUPIN14-043 from Plan Regional de Investigación del Principado de Asturias, Spain. Both national and regional grants received cofounding from the European Union FEDER funds. SA is the recipient of a postdoctoral Marie Curie contract funded by the EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Age-Associated Changes in Gut Microbiota and Dietary Components Related with the Immune System in Adulthood and Old Age: A Cross-Sectional Study

  • Salazar, Nuria
  • Arboleya, Silvia
  • Fernández-Navarro, Tania
  • González de los Reyes-Gavilán, Clara
  • González Solares, Sonia
  • Gueimonde Fernández, Miguel
The fecal microbiota plays an important role in human health, and alterations in the microbiota–host interaction seem to be involved in the ageing process. Therefore, it is of interest to develop strategies for promoting a balanced microbiota in old age in order to prevent the physiological and immune decline associated with age. However, the specific microbiota changes in the transition from adulthood to senescence are not yet well understood. Here we assessed the levels of some intestinal microorganisms and short chain fatty acids (SCFAs) across different age-groups. In total, 153 adults from four age groups (<50, 50–65, 66–80, and >80 years-old) were recruited; the levels of different bacterial groups in fecal samples were determined by quantitative polymerase chain reaction (qPCR), and those of SCFA by gas chromatography. Dietary information was collected by using a Food Frequency Questionnaire. The presence of the Bifidobacterium, Faecalibacterium, Bacteroides group, and Clostridium cluster XIVa decreased with age up to 66–80 years of age, with differences reaching statistical significance for the latter group. Interestingly, the levels of some of these microorganisms recovered in the very old age group (>80 years), with these older individuals presenting significantly higher counts of Akkermansia and Lactobacillus group than adults and the younger elderly. In addition, ageing was associated with a progressively and statistically significant reduction in the fecal concentrations of SCFAs. Dietary intakes also showed some statistically significant differences among the groups for some macro- and micronutrients. Moreover, associations of some microorganisms with age and macronutrients were also evidenced. Considering the role that fecal microbiota alterations may have in terms of impairing homeostasis and resilience, our results underline the importance of understanding the ageing and immunosenescence processes by including the microbiota perspective., This research was funded by the Plan Nacional de I+D of the Ministry of Economy and Competitiveness (projects AGL2013-43770-R and AGL2017-83653R) and from the Alimerka Foundation (Spain). NS is the recipient of a postdoctoral contract awarded by the Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA), whereas SA is the recipient of a Marie Curie contract funded by the EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Nutritional composition of processed baby foods targeted at infants from 0–12 months

  • Gómez-Martín, María
  • Arboleya, Silvia
  • Gueimonde Fernández, Miguel
  • González Solares, Sonia
In the last decade, there has been an increasing demand for ready-to-eat infant meals in Spain. However, the used food composition databases do not include processed products intended for infants under 12 months of age. Thus, we aimed at the creation of a food composition table including these products. Nutritional composition data were collected from the label of 568 products including infant formula, cereal products and complementary foods (mixed puree or snacks and desserts); additionally, breast-milk (11 preterm and term samples) nutritional composition were estimated from scientific publications available to date. Information was compiled into a table available in “open access” at the website http://ucc.uniovi.es/formacioncientifica/recursosinv including information about 53 dietary components of infant formula, 28 for breast milk, 30 for cereal products and 14 for complementary foods. The infant formula¿s composition from 0 to 6 months were found similar to the values reported for mature breast milk (10–12 weeks) but different from breast milk from 1 to 4 weeks. One serving of cereals has been found to satisfy more than the 50% of the DRI for protein and carbohydrates. This information constitutes an essential step in order to understand the diet-health relationships in the early stages of life in the Spanish population., This work was financed by the EU Joint Programming Initiative—A Healthy Diet for a Healthy Life and the Spanish Ministry of Economy and Competitiveness (MINECO) (Project EarlyMicroHealth), and by project AGL2017-83653R from Plan Estatal de I+D+I (Spanish Ministry of Economy and Competitiveness)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Establecimiento de la población bifidobacteriana en niños prematuros

  • Arboleya, Silvia
  • Saturio López, Silvia
  • Suárez, Marta
  • Solís, Gonzalo
  • Fernández, Nuria
  • Mancabelli, Leonardo
  • Milani, Christian
  • Ventura, Marco
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
Trabajo presentado en la 13ª Reunión de la Red Española de Bacterias Lácticas (RedBAL), celebrada en Madrid (España) del 137 al 18 de junio de 2019, El correcto establecimiento de la microbiota intestinal al inicio de la vida es crítico para la posterior salud del hospedador. La colonización del intestino conlleva el ensamblaje de novo de toda una comunidad microbiana, muy heterogénea y compleja, y se ve afectado por diferentes factores pre-, peri- y post-natales. La prematuridad es uno de los factores que afecta al correcto establecimiento de la microbiota intestinal debido a la inmadurez de los órganos del recién nacido, los largos periodos de tiempo que pasan en el hospital, las medicaciones de diferente tipo que reciben, las dificultades que sufren para la alimentación oral, etc. Diferentes estudios han identificado alteraciones en el establecimiento de la microbiota intestinal del prematuro, siendo el género Bifidobacterium uno de los más afectados. Las bifidobacterias son uno de los primeros y más numerosos colonizadores en la microbiota intestinal de niños sanos alimentados con leche materna. Numerosos estudios han asociado a las bifidobacterias con un buen estado de salud y son ampliamente utilizadas como probióticos. El objetivo de este trabajo ha sido el estudio del establecimiento y desarrollo de las diferentes poblaciones de especies de bifidobacterias en niños prematuros, comparados con niños sanos nacidos a término, durante los primeros tres meses de vida. Con dicho objetivo se utilizó ADN aislado de muestras fecales que fue analizado mediante PCR cuantitativa y el análisis de la región intergénica 16S-23S por secuenciación masiva. Se observaron importantes diferencias en la composición de bifidobacterias entre ambos grupos de niños a lo largo de los primeros meses de vida. Los niños prematuros mostraron mayores niveles de la especie Bifidobacterium breve a partir del mes de edad y niveles significativamente menores de Bifidobacterium longum, Bifidobacterium bifidum y Bifidobacterium dentium a lo largo del muestreo. La secuenciación de la región intergénica ITS, permitió ahondar más en las abundancias de especies minoritarias, mostrando diferencias entre ambos grupos también en Bifidobacterium asteroides y Bifidobacterium pseudolongum. Así mismo los resultaros obtenidos pusieron de manifiesto la existencia de diferencias en el establecimiento de las poblaciones de bifidobacterias en los niños prematuros en función de diferentes factores perinatales. Estos resultados ponen de manifiesto profundas alteraciones en el proceso de establecimiento de la microbiota intestinal en niños prematuros, incluso a nivel de especie, lo cual apoya la necesidad de implementar estrategias de intervención dietética dirigidas a corregir dichas alteraciones de una manera específica y dirigida., MINECO (Proyectos PCIN-2015-233 y AGL2017-83653-R) y Marie Sklodowska-Curie Actions.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Long-Term Coffee Consumption is Associated with Fecal Microbial Composition in Humans

  • González Solares, Sonia
  • Salazar, Nuria
  • Ruiz-Saavedra, Sergio
  • Gómez-Martín, María
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
© 2020 by the authors., Coffee consumption has been related to a preventive effect against several non-transmissible pathologies. Due to the content of this beverage in phytochemicals and minerals, it has been proposed that its impact on health may partly depend on gut microbiota modulation. Our aim was to explore the interaction among gut microbiota, fecal short chain fatty acids, and health-related parameters in 147 healthy subjects classified according to coffee consumption, to deepen the association of the role of the (poly)phenol and alkaloid content of this beverage. Food daily intake was assessed by an annual food frequency questionnaire (FFQ). Coffee consumption was categorized into three groups: non-coffee-consumers (0–3 mL/day), moderate consumers (3–45 mL/day) and high-coffee consumers (45–500 mL/day). Some relevant groups of the gut microbiota were determined by qPCR, and concentration of fecal short chain fatty acids by gas chromatography. Serum health related biomarkers were determined by standardized methods. Interestingly, a higher level of Bacteroides–Prevotella–Porphyromonas was observed in the high consumers of coffee, who also had lower levels of lipoperoxidation. Two groups of coffee-derived (poly)phenol, methoxyphenols and alkylphenols, and caffeine, among alkaloids, were directly associated with Bacteroides group levels. Thus, regular consumption of coffee appears to be associated with changes in some intestinal microbiota groups in which dietary (poly)phenol and caffeine may play a role., This research was funded by Plan Estatal de I+D+I through projects AGL2017-83653-R (AEI/FEDER, UE) and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE), and by contracts with Biopolis SL (Valencia, Spain), CAUCE Foundation (Oviedo, Spain) and Alimerka Foundation (Llanera, Spain). N.S. was granted a postdoctoral contract awarded by the Fundación para la Investigación Biosanitaria de Asturias (FINBA); M.G-M. was supported by a FPU (FPU18/03393) predoctoral grant from the Spanish Ministry of Science, Innovation and Universities; and S.R.-S. is the recipient of a Research Training contract awarded under project RTI2018-098288-B-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Donated Human Milk as a Determinant Factor for the Gut Bifidobacterial Ecology in Premature Babies

  • Arboleya, Silvia
  • Saturio López, Silvia
  • Suárez, Marta
  • Fernández, Nuria
  • Mancabelli, Leonardo
  • González de los Reyes-Gavilán, Clara
  • Ventura, Marco
  • Solís, Gonzalo
  • Gueimonde Fernández, Miguel
© 2020 by the authors., Correct establishment of the gut microbiome is compromised in premature babies, with Bifidobacterium being one of the most affected genera. Prematurity often entails the inability to successfully breastfeed, therefore requiring the implementation of other feeding modes; breast milk expression from a donor mother is the recommended option when their own mother’s milk is not available. Some studies showed different gut microbial profiles in premature infants fed with breast milk and donor human milk, however, it is not known how this affects the species composition of the genus Bifidobacterium. The objective of this study was to assess the effect of donated human milk on shaping the gut bifidobacterial populations of premature babies during the first three months of life. We analyzed the gut bifidobacterial communities of 42 premature babies fed with human donor milk or own-mother milk by the 16S rRNA–23S rRNA internal transcriber spaces (ITS) region sequencing and q-PCR. Moreover, metabolic activity was assessed by gas chromatography. We observed a specific bifidobacterial profile based on feeding type, with higher bifidobacterial diversity in the human donor milk group. Differences in specific Bifidobacterium species composition may contribute to the development of specific new strategies or treatments aimed at mimicking the impact of own-mother milk feeding in neonatal units., This project received funding from EU Joint Programming Initiative—A Healthy Diet for a Healthy Life (JPI HDHL, http://www.healthydietforhealthylife.eu/, Spanish Ministry of Economy and Competitiveness (MINECO) Project EarlyMicroHealth), by project AGL2017-83653R from Plan Estatal de I+D+I (MINECO) and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 749255. S.A was the recipient of a postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities, Ref. IJCI-2017-32156)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases

  • Arias, Natalia
  • Arboleya, Silvia
  • Allison, Joseph
  • Kaliszewska, Aleksandra
  • Higarza, Sara G.
  • Gueimonde Fernández, Miguel
  • Arias, Jorge L.
© 2020 by the authors., Choline is a water-soluble nutrient essential for human life. Gut microbial metabolism of choline results in the production of trimethylamine (TMA), which, upon absorption by the host is converted into trimethylamine-N-oxide (TMAO) in the liver. A high accumulation of both components is related to cardiovascular disease, inflammatory bowel disease, non-alcoholic fatty liver disease, and chronic kidney disease. However, the relationship between the microbiota production of these components and its impact on these diseases still remains unknown. In this review, we will address which microbes contribute to TMA production in the human gut, the extent to which host factors (e.g., the genotype) and diet affect TMA production, and the colonization of these microbes and the reversal of dysbiosis as a therapy for these diseases., This work was supported by the Ministry of Science, Innovation and Universities (PSI2017-83893-R to J.L.A.) and the Ministry of Economy and Business (PSI2015-73111-EXP to J.L.A., PSI2017-90806-REDT to J.L.A. and AGL2017-83653R to M.G.) (Spain). S.A. was the recipient of a postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities, Ref. IJCI-2017-32156)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

New players in the relationship between diet and microbiota: the role of macromolecular antioxidant polyphenols

  • Gutiérrez-Díaz, Isabel
  • Salazar, Nuria
  • Pérez-Jiménez, Jara
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
  • González Solares, Sonia
[Purpose]: Solid evidence has emerged supporting the role of polyphenols and fibers as gut microbiota modulators. These studies have been limited to the data available in food composition databases, which did not include the food content of non-extractable polyphenols (NEPP). The main objective of this work is to quantify the intake of the different types of dietary polyphenols including NEPP and to evaluate their impact on the composition and activity of the intestinal microbiota., [Methods]: Cross-sectional descriptive study conducted on a sample of 147 adults with no declared pathologies. Dietary intake has been registered by a semi-quantitative Food Frequency Questionnaire (FFQ) and transformed into extractable (EPP) and NEPP, and dietary fibers based on available databases. Major phylogenetic types of the intestinal microbiota were determined by qPCR and fecal SCFA quantification was performed by gas chromatography., [Results]: NEPP account for two-thirds of the total polyphenols intake. A combined analysis by stepwise regression model including all dietary fiber and (poly)phenols has identified hydrolysable (poly)phenol (HPP) intake, as the best predictor of Bacteroides–Prevotella–Porphyromonas group and Bifidobacterium levels in feces. Also, HPPs were positively associated with butyric acid, while insoluble fiber was identified as a predictor of propionic acid in feces., [Conclusion]: The intake of macromolecular (poly)phenols could contribute to modulate the gut microbiota by increasing the levels of certain intestinal microorganisms with proven health benefits., This research was funded by Plan Estatal de I + D + I through projects AGL2017-83653-R (AEI/FEDER, UE) and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE) and by contracts with Biopolis SL (Valencia, Spain), CAUCE Foundation (Oviedo, Spain) and Alimerka Foundation (Llanera, Spain). NS. is granted by a postdoctoral contract awarded by the Fundación para la Investigación Biosanitaria de Asturias (FINBA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

An overview on fecal branched short-chain fatty acids along human life and as related with body mass index: Associated dietary and anthropometric factors

  • Rios-Covián, David
  • González Solares, Sonia
  • Nogacka, Alicja
  • Arboleya, Silvia
  • Salazar, Nuria
  • Gueimonde Fernández, Miguel
  • González de los Reyes-Gavilán, Clara
Short-chain fatty acids (SCFA) are the main bacterial products of the catabolism of carbohydrates and proteins in the gut, and their role is essential in host–microbiota interactions. Acetic, propionic, and butyric acids are the major SCFA produced in the gut, and they have been extensively studied. In contrast, branched short-chain fatty acids (BCFA), mainly isovaleric and isobutyric acids, are produced in less amounts and their fecal levels in different human groups, intestinal microbial producing populations, and influence on health are insufficiently known. They have been proposed as markers of protein fermentation, which leads to the concomitant production of other fermentation products that can be harmful for the colon epithelium. In this context, the aim of this study was to shed light into the production of BCFA by the human intestinal microbiota, as related to age, body mass index (BMI), and diet. Fecal levels of the different SCFA were analyzed by gas chromatography in 232 healthy individuals with ages between 3 months and 95 years, and BMI in adults ranging from 19 to 54. Dietary assessments in adults were obtained through a food frequency questionnaire (FFQ). Molar proportions of BCFA in feces were strongly and positively related with aging. However, not a significant relationship was obtained between BCFA and BMI. A negative correlation was found between the consumption of dietary insoluble fiber and fecal levels of BCFA. More studies are needed for improving our understanding on the relationship of BCFA production profile with the intestinal microbiota composition and human health., The present work was financed by projects AGL2017-83653-R (AEI/FEDER, UE), RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE), and PCIN-2015-233 (Project EarlyMicroHealth from the EU Joint Program Initiative HDHL) (MINECO/FEDER, UE), GRUPIN14-043 funded by Plan Regional de Investigación del Principado de Asturias, Spain, and contracts with Biopolis SL (Valencia, Spain), CAUCE Foundation (Oviedo, Spain), and Alimerka Foundation (Llanera, Spain). AN was the recipient of a predoctoral contract granted by MINECO (BES-2014-068796). NS was granted by a Juan de la Cierva postdoctoral contract from MINECO and is currently the recipient of a postdoctoral contract awarded by the Fundación para la Investigación Biosanitaria de Asturias (FINBA). SA is currently financed by a Postdoctoral Marie Slodowska Curie contract funded by EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Comparison of Different Dietary Indices as Predictors of Inflammation, Oxidative Stress and Intestinal Microbiota in Middle-Aged and Elderly Subjects

  • Ruiz-Saavedra, Sergio
  • Salazar, Nuria
  • Suárez, Ana
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
  • González Solares, Sonia
© 2020 by the authors., During the last decades the gut microbiota has been identified as a key mediator in the diet-health interaction. However, our understanding on the impact of general diet upon microbiota is still limited. Dietary indices represent an essential approach for addressing the link between diet and health from a holistic point of view. Our aim was to test the predictive potential of seven dietary ratings on biomarkers of inflammation, oxidative stress and on the composition and metabolic activity of the intestinal microbiota. A cross-sectional descriptive study was conducted on a sample of 73 subjects aged >50 years with non-declared pathologies. Dietary inflammatory index (DII), Empirical Dietary Inflammatory Index (EDII), Healthy Eating Index (HEI), Alternative Healthy Eating Index (AHEI), Mediterranean adapted Diet Quality Index-International (DQI-I), Modified Mediterranean Diet Score (MMDS) and relative Mediterranean Diet Score (rMED) were calculated based on a Food Frequency Questionnaire. Major phylogenetic types of the intestinal microbiota were determined by real time polymerase chain reaction (qPCR) and fecal short chain fatty acids (SCFAs) by gas chromatography. While DII, HEI, DQI-I and MMDS were identified as predictors of Faecalibacterium prausnitzii levels, AHEI and MMDS were negatively associated with Lactobacillus group. HEI, AHEI and MMDS were positively associated with fecal SCFAs. In addition, DII and EDII explained lipoperoxidation level and Mediterranean scores the serum IL-8 concentrations. The lower detection of IL-8 in individuals with higher scores on Mediterranean indices may be partially explained by the increased levels of the anti-inflammatory bacterium F. prausnitzii in such individuals., This research was funded by Plan Estatal de I+D+I through projects AGL2017-83653-R (AEI/FEDER, UE) and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE) and by contracts with Biopolis SL (Valencia, Spain), CAUCE Foundation (Oviedo, Spain) and Alimerka Foundation (Llanera, Spain). N.S. is granted a postdoctoral contract awarded by the Fundación para la Investigación Biosanitaria de Asturias (FINBA) and S.R.-S. is the recipient of a Research Training contract awarded under project RTI2018-098288-B-I00., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Levels of Predominant Intestinal Microorganisms in 1 Month-Old Full-Term Babies and Weight Gain during the First Year of Life

  • González Solares, Sonia
  • Selma Royo, Marta
  • Arboleya, Silvia
  • Martínez-Costa, Cecilia
  • Solís, Gonzalo
  • Suárez, Marta
  • Fernández, Nuria
  • González de los Reyes-Gavilán, Clara
  • Díaz-Coto, Susana
  • Martínez-Camblor, Pablo
  • Collado, María Carmen
  • Gueimonde Fernández, Miguel
The early life gut microbiota has been reported to be involved in neonatal weight gain and later infant growth. Therefore, this early microbiota may constitute a target for the promotion of healthy neonatal growth and development with potential consequences for later life. Unfortunately, we are still far from understanding the association between neonatal microbiota and weight gain and growth. In this context, we evaluated the relationship between early microbiota and weight in a cohort of full-term infants. The absolute levels of specific fecal microorganisms were determined in 88 vaginally delivered and 36 C-section-delivered full-term newborns at 1 month of age and their growth up to 12 months of age. We observed statistically significant associations between the levels of some early life gut microbes and infant weight gain during the first year of life. Classifying the infants into tertiles according to their Staphylococcus levels at 1 month of age allowed us to observe a significantly lower weight at 12 months of life in the C-section-delivered infants from the highest tertile. Univariate and multivariate models pointed out associations between the levels of some fecal microorganisms at 1 month of age and weight gain at 6 and 12 months. Interestingly, these associations were different in vaginally and C-section-delivered babies. A significant direct association between Staphylococcus and weight gain at 1 month of life was observed in vaginally delivered babies, whereas in C-section-delivered infants, lower Bacteroides levels at 1 month were associated with higher later weight gain (at 6 and 12 months). Our results indicate an association between the gut microbiota and weight gain in early life and highlight potential microbial predictors for later weight gain., This work was funded by the EU Joint Programming Initiative—A Healthy Diet for a Healthy Life (JPI HDHL. http://www.healthydietforhealthylife.eu/; accessed on 14 July 2021. Project EarlyMicroHealth) and the Project AGL2017-83653R funded by the Spanish “Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and FEDER” and by the European Research Council under the European Union’s Horizon 2020 research and innovation program (ERC starting grant, no. 639226). Silvia Arboleya is the recipient of a Juan de la Cierva Postdoctoral Contract from the Spanish Ministry of Science and Innovation (Ref. IJCI-2017-32156) funded by the Spanish Ministry of Science, Innovation and Universities., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats

  • Higarza, Sara G.
  • Arboleya, Silvia
  • Arias, Jorge L.
  • Gueimonde Fernández, Miguel
  • Arias, Natalia
Nonalcoholic steatohepatitis (NASH) is one of the most prevalent diseases globally. A high-fat, high-cholesterol (HFHC) diet leads to an early NASH model. It has been suggested that gut microbiota mediates the effects of diet through the microbiota–gut–brain axis, modifying the host’s brain metabolism and disrupting cognition. Here, we target NASH-induced cognitive damage by testing the impact of environmental enrichment (EE) and the administration of either Lacticaseibacillus rhamnosus GG (LGG) or Akkermansia muciniphila CIP107961 (AKK). EE and AKK, but not LGG, reverse the HFHC-induced cognitive dysfunction, including impaired spatial working memory and novel object recognition; however, whereas AKK restores brain metabolism, EE results in an overall decrease. Moreover, AKK and LGG did not induce major rearrangements in the intestinal microbiota, with only slight changes in bacterial composition and diversity, whereas EE led to an increase in Firmicutes and Verrucomicrobia members. Our findings illustrate the interplay between gut microbiota, the host’s brain energy metabolism, and cognition. In addition, the findings suggest intervention strategies, such as the administration of AKK, for the management of the cognitive dysfunction related to NASH., This work was supported by the Ministry of Science, Innovation and Universities [PSI2017-83893-R to JLA] and the Ministry of Economy and Business [PSI2017-90806-REDT to JLA and AGL2017-83653R to MG] (Spain). S.A was the recipient of a postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities, [Ref. IJCI- 2017-32156]. The funders had no role in the study design or data collection.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

In vitro Selection of Probiotics for Microbiota Modulation in Normal-Weight and Severely Obese Individuals: Focus on Gas Production and Interaction With Intestinal Epithelial Cells

  • Nogacka, Alicja
  • González de los Reyes-Gavilán, Clara
  • Arboleya, Silvia
  • Ruas-Madiedo, Patricia
  • Martinez-Faedo, Ceferino
  • Suárez, Adolfo
  • He, Fang
  • Harata, Gaku
  • Endo, Akihito
  • Salazar, Nuria
  • Gueimonde Fernández, Miguel
The intestinal microbiota plays important roles in the maintenance of health. Strategies aiming at its modulation, such as probiotics, have received a deal of attention. Several strains have been studied in different in vitro models; however, the correlation of results obtained with the in vivo data has been limited. This questions the usefulness of such in vitro selection models, traditionally relying on over-simplified tests, not considering the influence of the accompanying microbiota or focusing on microbiota composition without considering functional traits. Here we assess the potential of six Bifidobacterium, Lactobacillus and Lacticaseibacillus strains in an in vitro model to determine their impact on the microbiota not just in terms of composition but also of functionality. Moreover, we compared the responses obtained in two different population groups: normal-weight and severely obese subjects. Fecal cultures were conducted to evaluate the impact of the strains on specific intestinal microbial groups, on the production of short-chain fatty acids, and on two functional responses: the production of gas and the interaction with human intestinal epithelial cells. The response to the different probiotics differed between both human groups. The addition of the probiotic strains did not induce major changes on the microbiota composition, with significant increases detected almost exclusively for the species added. Higher levels of gas production were observed in cultures from normal-weight subjects than in the obese population, with some strains being able to significantly reduce gas production in the latter group. Moreover, in obese subjects all the Bifidobacterium strains tested and Lacticaseibacillus rhamnosus GG were able to modify the response of the intestinal cells, restoring values similar to those obtained with the microbiotas of normal-weight subjects. Our results underline the need for the screening and selection of probiotics in a target-population specific manner by using appropriate in vitro models before enrolling in clinical intervention trials., The present work was mainly financed by the project AGL2013-43770-R (receiving funds from the Ministry of Economy and Competitiveness—MINECO and the European Union FEDER funds), and partly by projects AGL2017-83653-R (AEI/FEDER, UE), and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE) and by a contract with the company Takanashi Milk Products (Yokohama, Japan). AN was the recipient of a predoctoral contract granted by MINECO (reference BES-2014-068796). SA is currently financed by a postdoctoral Juan de la Cierva contract (Ministry of Science, Innovation and Universities, Spain, ref. IJCI-2017-32156) and NS is currently the recipient of a postdoctoral contract awarded by the Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Impacto de la obesidad severa y la pérdida de peso sobre la microbiota y el metaboloma fecal

  • Nogacka, Alicja
  • González de los Reyes-Gavilán, Clara
  • Martinez-Faedo, Ceferino
  • Ruas-Madiedo, Patricia
  • Suárez, Adolfo
  • Mancabelli, Leonardo
  • Ventura, Marco
  • Cifuentes, Alejandro
  • León, Carlos
  • Gueimonde Fernández, Miguel
  • Salazar, Nuria
Trabajo presentado al XXVIII Congreso Nacional de Microbiología, celebrado en formato virtual, durante los días 28 de junio a 2 de julio de 2021., Agradecimientos: Proyectos AGL2013-43770-R, AGL2017-83653-R y RTI2018-098288- B-I00, contratos BES-2014-068796 y IJCI-2015-19885., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Impact of extreme obesity and diet-induced weight loss on the fecal metabolome and gut microbiota

  • Nogacka, Alicja
  • González de los Reyes-Gavilán, Clara
  • Martinez-Faedo, Ceferino
  • Ruas-Madiedo, Patricia
  • Suárez, Adolfo
  • Mancabelli, Leonardo
  • Ventura, Marco
  • Cifuentes, Alejandro
  • León, Carlos
  • Gueimonde Fernández, Miguel
  • Salazar, Nuria
[Scope]: A limited number of human studies have characterized fecal microbiota and metabolome in extreme obesity and after diet-induced weight loss., [Methods and results]: Fecal samples from normal-weight and extremely obese adults and from obese participants before and after moderate diet-induced weight loss are evaluated for their interaction with the intestinal adenocarcinoma cell line HT29 using an impedance-based in vitro model, which reveals variations in the interaction between the gut microbiota and host linked to obesity status. Microbiota composition, short chain fatty acids, and other intestinal metabolites are further analyzed to assess the interplay among diet, gut microbiota, and host in extreme obesity. Microbiota profiles are distinct between normal-weight and obese participants and are accompanied by fecal signatures in the metabolism of biliary compounds and catecholamines. Moderate diet-induced weight loss promotes shifts in the gut microbiota, and the primary fecal metabolomics features are associated with diet and the gut–liver and gut–brain axes., [Conclusions]: Analyses of the fecal microbiota and metabolome enable assessment of the impact of diet on gut microbiota composition and activity, supporting the potential use of certain fecal metabolites or members of the gut microbiota as biomarkers for the efficacy of weight loss in extreme obesity., The present work was mainly financed by the project AGL2013-43770-R (receiving funds from the Ministry of Economy and Competitiveness—MINECO and the European Union FEDER funds), and partly by projects AGL2017-83653-R (AEI/FEDER, UE), and RTI2018-098288-B-I00 (MCIU/AEI/FEDER, UE). A.M.N. was the recipient of a predoctoral contract granted by MINECO (reference BES-2014-068796) and N.S. received a postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities, Spain, reference IJCI-2015-19885) and currently she has a postdoctoral contract awarded by the Biosanitary Research Foundation in Asturias (FINBA, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Early-life development of the bifidobacterial community in the infant gut

  • Saturio López, Silvia
  • Nogacka, Alicja
  • Suárez, Marta
  • Fernández, Nuria
  • Mantecón, Laura
  • Mancabelli, Leonardo
  • Milani, Christian
  • Ventura, Marco
  • González de los Reyes-Gavilán, Clara
  • Solís, Gonzalo
  • Arboleya, Silvia
  • Gueimonde Fernández, Miguel
The establishment of the gut microbiota poses implications for short and long-term health. Bifidobacterium is an important taxon in early life, being one of the most abundant genera in the infant intestinal microbiota and carrying out key functions for maintaining host-homeostasis. Recent metagenomic studies have shown that different factors, such as gestational age, delivery mode, or feeding habits, affect the gut microbiota establishment at high phylogenetic levels. However, their impact on the specific bifidobacterial populations is not yet well understood. Here we studied the impact of these factors on the different Bifidobacterium species and subspecies at both the quantitative and qualitative levels. Fecal samples were taken from 85 neonates at 2, 10, 30, 90 days of life, and the relative proportions of the different bifidobacterial populations were assessed by 16S rRNA–23S rRNA internal transcribed spacer (ITS) region sequencing. Absolute levels of the main species were determined by q-PCR. Our results showed that the bifidobacterial population establishment is affected by gestational age, delivery mode, and infant feeding, as it is evidenced by qualitative and quantitative changes. These data underline the need for understanding the impact of perinatal factors on the gut microbiota also at low taxonomic levels, especially in the case of relevant microbial populations such as Bifidobacterium. The data obtained provide indications for the selection of the species best suited for the development of bifidobacteria-based products for different groups of neonates and will help to develop rational strategies for favoring a healthy early microbiota development when this process is challenged., This work was funded by the EU Joint Programming Initiative—A Healthy Diet for a Healthy Life (JPI HDHL, http://www.healthydietforhealthylife.eu/, Project EarlyMicroHealth) and the Project AGL2017-83653R funded by the Spanish “Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and FEDER”. S.A. was the recipient of a Juan de la Cierva Postdoctoral Contract (Ministry of Science, Innovation, and Universities, Ref. IJCI-2017-32156) and an EU Horizon2020 research grant under the Marie Sklodowska-Curie program (n. 749255).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effect of intrapartum antibiotics prophylaxis on the bifidobacterial establishment within the neonatal gut

  • Saturio López, Silvia
  • Suárez, Marta
  • Mancabelli, Leonardo
  • Fernández, Nuria
  • Mantecón, Laura
  • González de los Reyes-Gavilán, Clara
  • Ventura, Marco
  • Gueimonde Fernández, Miguel
  • Arboleya, Silvia
  • Solís, Gonzalo
Antibiotics are important disruptors of the intestinal microbiota establishment, linked to immune and metabolic alterations. The intrapartum antibiotics prophylaxis (IAP) is a common clinical practice that is present in more than 30% of labours, and is known to negatively affect the gut microbiota composition. However, little is known about how it affects to Bifidobacterium (sub)species level, which is one of the most important intestinal microbial genera early in life. This study presents qualitative and quantitative analyses of the bifidobacterial (sub)species populations in faecal sam-ples, collected at 2, 10, 30 and 90 days of life, from 43 healthy full-term babies, sixteen of them delivered after IAP use. This study uses both 16S rRNA–23S rRNA internal transcribed spacer (ITS) region sequencing and q-PCR techniques for the analyses of the relative proportions and absolute levels, respectively, of the bifidobacterial populations. Our results show that the bifidobacterial populations establishment is affected by the IAP at both quantitative and qualitative levels. This practice can promote higher bifidobacterial diversity and several changes at a compositional level. This study underlines specific targets for developing gut microbiota-based products for favouring a proper bifidobacterial microbiota development when IAP is required., This project has received funding from the Project AGL2017-83653R funded by the Spanish “Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and FEDER” and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 749255. S.A. was the recipient of a postdoctoral Juan de la Cierva Contract (Ministry of Science, Innovation and Universities, Ref. IJCI-2017-32156).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of bifidobacteria on infant health

  • Saturio López, Silvia
  • Nogacka, Alicja
  • Alvarado-Jasso, Guadalupe Monserrat
  • Salazar, Nuria
  • González de los Reyes-Gavilán, Clara
  • Gueimonde Fernández, Miguel
  • Arboleya, Silvia
Bifidobacteria are among the predominant microorganisms during infancy, being a dominant microbial group in the healthy breastfed infant and playing a crucial role in newborns and infant development. Not only the levels of the Bifidobacterium genus but also the profile and quantity of the different bifidobacterial species have been demonstrated to be of relevance to infant health. Although no definitive proof is available on the causal association, reduced levels of bifidobacteria are perhaps the most frequently observed alteration of the intestinal microbiota in infant diseases. Moreover, Bifidobacterium strains have been extensively studied by their probiotic attributes. This review compiles the available information about bifidobacterial composition and function since the beginning of life, describing different perinatal factors affecting them, and their implications on different health alterations in infancy. In addition, this review gathers exhaustive information about pre‐clinical and clinical studies with Bifidobacterium strains as probiotics in neonates., This review has received funding from the Project AGL2017-83653R funded by the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU)/Agencia Estatal de Investigación (AEI/10.13039/501100011033/) and FEDER “Una manera de hacer Europa”. S.A. was the recipient of a postdoctoral Juan de la Cierva-Incorporación Contract (Ref. IJCI-2017-32156) funded by MCIU/AEI/10.13039/501100011033.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Gut Microbiota in Infants: Focus on Bifidobacterium

  • Solís, Gonzalo
  • Gueimonde Fernández, Miguel
A long time has passed since the initial pioneering works were carried out on the composition of infant microbiota by Thedore Escherich (1857–1911) and Ernst Moro (1874–1951), and since the observations of Henry Tissier (1866–1916) which linked “Bacillus bifidus” to the health of babies [...], This work has been funded by Grants AGL2017-83653R and PID2021-125337OB-I00 from MCIN/AEI/10.13039/50110001103/FEDER/UE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

2-Fucosyllactose Metabolism by Bifidobacteria Promotes Lactobacilli Growth in Co-Culture

  • Nogacka, Alicja
  • Cuesta Suárez, Isabel
  • Gueimonde Fernández, Miguel
  • González de los Reyes-Gavilán, Clara
Breastfeeding is recognized as the gold standard in infant nutrition, not only because of breastmilk’s intrinsic nutritional benefits but also due to the high content of different bioactive components such as 2-fucosyllactose (2′FL) in the mother’s milk. It promotes the growth of its two major consumers, Bifidobacterium longum ssp. infantis and Bifidobacterium bifidum, but the effect on other intestinal microorganisms of infant microbiota remains incompletely understood. pH-uncontrolled fecal cultures from infants donors identified as “fast 2′FL -degrader” microbiota phenotype were used for the isolation of 2′FL-associated microorganisms. The use of specific selective agents allowed the successful isolation of B. bifidum IPLA20048 and of Lactobacillus gasseri IPLA20136. The characterization of 2′FL consumption and its moieties has revealed more pronounced growth, pH drop, and lactic acid production after 2′FL consumption when both microorganisms were grown together. The results point to an association between B. bifidum IPLA20048 and L. gasseri IPLA20136 in which L. gasseri is able to use the galactose from the lactose moiety after the hydrolysis of 2′FL by B. bifidum. The additional screening of two groups of bifidobacteria (n = 38), fast and slow degraders of 2′FL, in co-culture with lactobacilli confirmed a potential cross-feeding mechanism based on degradation products released from bifidobacterial 2′FL break-down. Our work suggests that this phenomenon may be widespread among lactobacilli and bifidobacteria in the infant gut. More investigation is needed to decipher how the ability to degrade 2′FL and other human milk oligosaccharides could influence the microbiota establishment in neonates and the evolution of the microbiota in adult life., This work has been funded by Grants AGL2017-83653R and PID2021-125337OB-I00 from MCIN/AEI/10.13039/50110001103/FEDER/UE and project AYUD/2021/50981 from the Principality of Asturias to support the activity of research groups., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genetic strategies for sex-biased persistence of gut microbes across human life

  • Tarracchini, Chiara
  • Alessandri, Giulia
  • Fontana, Federico
  • Rizzo, Sonia Mirjam
  • Lugli, Gabriele Andrea
  • Bianchi, Massimiliano Giovanni
  • Mancabelli, Leonardo
  • Longhi, Giulia
  • Argentini, Chiara
  • Vergna, Laura Maria
  • Anzalone, Rosaria
  • Viappiani, Alice
  • Turroni, Francesca
  • Taurino, Giuseppe
  • Chiu, Martina
  • Arboleya, Silvia
  • Gueimonde Fernández, Miguel
  • Bussolati, Ovidio
  • Sinderen, Douwe van
  • Milani, Christian
  • Ventura, Marco
Although compositional variation in the gut microbiome during human development has been extensively investigated, strain-resolved dynamic changes remain to be fully uncovered. In the current study, shotgun metagenomic sequencing data of 12,415 fecal microbiomes from healthy individuals are employed for strain-level tracking of gut microbiota members to elucidate its evolving biodiversity across the human life span. This detailed longitudinal meta-analysis reveals host sex-related persistence of strains belonging to common, maternally-inherited species, such as Bifidobacterium bifidum and Bifidobacterium longum subsp. longum. Comparative genome analyses, coupled with experiments including intimate interaction between microbes and human intestinal cells, show that specific bacterial glycosyl hydrolases related to host-glycan metabolism may contribute to more efficient colonization in females compared to males. These findings point to an intriguing ancient sex-specific host-microbe coevolution driving the selective persistence in women of key microbial taxa that may be vertically passed on to the next generation., We thank GenProbio Srl for the financial support of the Laboratory of Probiogenomics. Part of this research is conducted using the High- Performance Computing (HPC) facility of the University of Parma. This research has financially been supported by the Programme “FIL-Quota Incentivante” of University of Parma and co-sponsored by Fondazione Cariparma”. D.v.S. is a member of APC Microbiome Ireland funded by Science Foundation Ireland (SFI), through the Irish Government’s National Development Plan (Grant no. SFI/12/RC/2273-P1 and SFI/12/RC/ 2273-P2). G.T. has been supported by “Fondazione Cariparma” in the framework of the project entitled “Parma Microbiota”. LMV has been supported by by “Programma Operativo Nazionale 2014–2020 of the Italian Ministry of University and Research. The funding from Project AGL2017-83653R (Spanish “Ministerio de Ciencia, Innovación y Universidades (MCIU)”, “Agencia Estatal de Investigación (AEI)” and FEDER) is also acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Impact of intrapartum antibiotics on the developing microbiota: a review

  • Arboleya, Silvia
  • Saturio López, Silvia
  • Gueimonde Fernández, Miguel
The perinatal period sets the basis for the later physiological and immune homeostasis of the individual, with the intestinal microbiota being an important contributor to driving this homeostasis development. Therefore, the initial establishment and later development of the microbiota during early life may play a key role in later health. This early establishment of the intestinal microbiota is known to be affected by several factors, with gestational age, delivery mode, and feeding habits being extensively studied ones. Other factors are not so well understood, although knowledge has been accumulating in the last years. Among them, a factor of great relevance is the effect of perinatal exposure to antibiotics. Administration of intrapartum antimicrobial prophylaxis (IAP) to women during the delivery process represents the most common form of exposure to antibiotics during the perinatal period, present in around 30% of deliveries. During the last decade, evidence has accumulated demonstrating that IAP alters intestinal microbiota development in neonates. Moreover, recent evidence indicates that this practice may also be altering the infant intestinal resistome by increasing the levels of some antibiotic resistance genes. This evidence, as reviewed in this manuscript, suggests the interest in promoting the rational use of IAP. This practice has significantly reduced the risk of neonatal infections, but now the accumulating knowledge suggests the need for strategies to minimize its impact on the neonatal microbiota establishment., This work was supported by Grant name AGL2017-83653R funded by the Spanish “Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and FEDER”. Arboleya S was the recipient of a Juan de la Cierva Postdoctoral Contract (Ministry of Science, Innovation and Universities, MCIN/AEI/10.13039/501100011033, Ref. IJCI-2017-32156) and Saturio S is the recipient of a predoctoral contract from ISPA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Probiotic-Induced Modulation of Microbiota Composition and Antibiotic Resistance Genes Load, an In Vitro Assessment

  • Nogacka, Alicja
  • Saturio López, Silvia
  • Alvarado-Jasso, Guadalupe Monserrat
  • Salazar, Nuria
  • González de los Reyes-Gavilán, Clara
  • Martinez-Faedo, Ceferino
  • Suárez, Adolfo
  • Wang, Ruipeng
  • Miyazawa, Kenji
  • Harata, Gaku
  • Endo, Akihito
  • Arboleya, Silvia
  • Gueimonde Fernández, Miguel
The imbalance of the gut microbiota (GM) is known as dysbiosis and is associated with disorders such as obesity. The increasing prevalence of microorganisms harboring antibiotic resistance genes (ARG) in the GM has been reported as a potential risk for spreading multi-drug-resistant pathogens. The objective of this work was the evaluation, in a fecal culture model, of different probiotics for their ability to modulate GM composition and ARG levels on two population groups, extremely obese (OB) and normal-weight (NW) subjects. Clear differences in the basal microbiota composition were observed between NW and OB donors. The microbial profile assessed by metataxonomics revealed the broader impact of probiotics on the OB microbiota composition. Also, supplementation with probiotics promoted significant reductions in the absolute levels of tetM and tetO genes. Regarding the blaTEM gene, a minor but significant decrease in both donor groups was detected after probiotic addition. A negative association between the abundance of Bifidobacteriaceae and the tetM gene was observed. Our results show the ability of some of the tested strains to modulate GM. Moreover, the results suggest the potential application of probiotics for reducing the levels of ARG, which constitutes an interesting target for the future development of probiotics., The present work was funded by project AGL2017-83653-R (AEI/FEDER, UE), by the project AYUD/2021/ 50981 from the Principality of Asturias, to support the activity of their research groups. The authors declare that this study has also received funding from Takanashi Milk Products (Yokohama, Japan). The funder had the following involvement with the study: metataxonomic analyses and review of the manuscript. S.A. was financed by a postdoctoral Juan de la Cierva contract (Ministry of Science, Innovation and Universities, Spain, ref. IJCI-2017-32156). A.M.N., S.S. and S.A. are currently the recipient of contracts awarded by the Fundación para la Investigación Biosanitaria de Asturias (FINBA)., Peer reviewed